Labcorp
940 hedge funds and large institutions have $18.2B invested in Labcorp in 2023 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 334 increasing their positions, 349 reducing their positions, and 93 closing their positions.
121% more call options, than puts
Call options by funds: $133M | Put options by funds: $60.1M
0.26% less ownership
Funds ownership: 104.44% → 104.18% (-0.26%)
4% less repeat investments, than reductions
Existing positions increased: 334 | Existing positions reduced: 349
5% less capital invested
Capital invested by funds: $19.1B → $18.2B (-$883M)
3% less funds holding
Funds holding: 970 → 940 (-30)
11% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 93
18% less funds holding in top 10
Funds holding in top 10: 22 → 18 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
Southpoint Capital Advisors
New York
|
+$144M |
| 2 |
BlackRock
New York
|
+$116M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$97M |
| 4 |
SC
Sessa Capital
New York
|
+$67.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$60.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$148M |
| 2 |
Goldman Sachs
New York
|
-$55.5M |
| 3 |
Morgan Stanley
New York
|
-$50.9M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$49.9M |
| 5 |
TP
Third Point
New York
|
-$45.2M |
LH Hedge Fund Activity: Q1 2023 in Review
940 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q1 2023, worth a combined $18.2B — down 4.6% from $19.1B a quarter earlier.
Sellers outnumbered buyers: 93 funds closed out of LH and 83 opened new positions — a net loss of 10 holders — while 349 trimmed existing stakes and 334 added.
The largest buyer was Southpoint Capital Advisors, opening a new position worth an estimated $144M. The largest seller was JP Morgan Chase, cutting an estimated $148M.
- 940 institutional investors held Labcorp (LH) as of Q1 2023, down from 970 in Q4 2022.
- Funds reported $18.2B of Labcorp stock for Q1 2023, down 4.6% quarter-over-quarter.
- 83 funds opened new Labcorp positions in Q1 2023 and 93 closed out, a net change of -10 holders.
- The largest Labcorp buyer in Q1 2023 was Southpoint Capital Advisors, an estimated $144M added.
- The largest Labcorp seller in Q1 2023 was JP Morgan Chase, an estimated $148M sold.
Based on aggregated 13F filings for Q1 2023.